Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concer...
Main Authors: | Eun Hye Kim, Hana Park, Kun Ho Lee, Sang Hoon Ahn, Seung-Min Kim, Kwang-Hyub Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2013-03-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-19-82.pdf |
Similar Items
-
Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B
by: Yue Ying, et al.
Published: (2018-04-01) -
Meta-analysis on Treatment of Chronic Hepatitis B with Telbivudine and Entecavir
by: Ye Zhen, et al.
Published: (2012-12-01) -
THE FIRST EXPERIENCE OF TELBIVUDINE THERAPY IN LIVER TRANSPLANT PATIENTS
by: O. A. Gerasimova, et al.
Published: (2010-06-01) -
Neutropenia caused by telbivudine in chronic hepatitis B patients: a report of one case
by: WANG Rongqi
Published: (2015-02-01) -
Comparison of Renal Safety of Tenofovir and Telbivudine in Chronic Hepatitis B Patients: A Real World Study in Indonesia
by: Rino Alvani Gani
Published: (2018-09-01)